KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today What Ensysce Biosciences ENSC disclosed about cash conversion Q4 2025 Earnings Beat Estimates OXLCN Oxford posts 74 percent Q4 2025 earnings miss shares edge slightly higher in todays trading RS Reliance beats earnings estimates by 73 yet shares fall 2 as investors eye growth outlook Deutsche Bank Aktiengesellschaft DB Posts Robust Q1 2026 Results Reaffirms 2028 Financial Targets BLDP Ballard posts narrower than expected Q4 2025 loss even as shares dip slightly in todays trading Devon Energy DVN Coterra Merger Bolsters Permian Scale Prioritizes Shareholder Capital Returns NUS Nu Skin shares slide 4 after earnings miss steeper 14 revenue drop raises concerns